IRTC

iRhythm Holdings, Inc. (IRTC) | Rumor.io

iRhythm Holdings

IRTC

Attention (50-day avg)0%

Attention rank (50-day avg)#3,046

Bullish sentiment (50-day avg)63%

Price to earnings ratio-81

Market capitalization3.7B

Earnings per share-0.42

Dividend yield (TTM)—

Revenue (annual)747.1M

Net income (annual)-44.6M

Social

What share of all stock conversation is about IRTC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% 0	0% 0

Jun 15

IRTC is breaking above its 50-day moving average, signaling a strong bullish trend.
The stochastic oscillator and MACD for IRTC are pointing upwards, indicating bullish momentum and potential for further upside.
IRTC is developing a bullish flag pattern and has solid bullish momentum, with potential for a breakout above key resistance levels.

Generated by AI

Sentiment

Of the messages about IRTC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	100% +50	85.07% -4.87
Bearish	—	0%	0% -50	14.93% +4.87

Bullish· Jan 14

Citigroup and Canaccord Genuity both raised iRhythm Technologies' price target, with Citigroup setting a new target of $165 and Canaccord Genuity setting a new target of $160.
Analysts' consensus on iRhythm Technologies is mildly bullish, with 79% of 16 analysts recommending a "Buy" rating.
The company's updated reimbursement rates have led to increased price targets from several Wall Street analysts, with Citigroup and Canaccord Genuity being two of the firms making such changes.

Bearish· Nov 4

$IRTC's recent price movement may be a fake pump, and the stock could correct significantly after earnings.
The company's FY21 sales guidance cut has led to a decline in iRhythm Technologies shares trading after hours.
iRhythm Technologies' FQ3 earnings report showed a loss of 81c EPS and $85.43M in revenue, which may indicate a downward trend for the stock.

Generated by AI

Topics

Of the messages about IRTC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	17.16%
Announcements	—	—	—	71.64%
Earnings	—	—	—	5.22%
Controversies	—	—	—	0.75%
Macro	—	—	—	0%
Technical Analysis	—	—	—	5.22%

Earnings· Nov 5

iRhythm Technologies (IRTC) reported Q3 GAAP EPS of -$0.74, missing estimates by $0.37.
Revenue for the quarter came in at $55.96M, beating estimates by $2.2M.
The company guided FY19 revenue in-line with expectations.

Analysts· Feb 24

Morgan Stanley cut iRhythm Technologies' price target to $151.00, maintaining an Overweight rating.
Needham upgraded iRhythm Technologies to Buy from Hold, setting a price target of $135.
Morgan Stanley maintained an Overweight rating for iRhythm Technologies, lowering the price target from $167 to $151.

Announcements· Mar 5

iRhythm Technologies, Inc. (IRTC) priced an upsized offering of $575.0 million of 1.50% convertible senior notes due 2029.
The company has increased shareholder value and expanded funding opportunities with this offering.
Quentin S., an insider, sold $3.0 million worth of iRhythm Technologies shares in the Health Care sector.

Generated by AI

Community

Of the messages about IRTC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	92.31%	35.11%
Newcomers	—	0%	7.69%	64.89%

Regulars· Aug 1

The company reported a Q2 loss of $0.32 per share, beating the FactSet consensus by $0.17, and saw revenues rise 26.1% year-over-year to $186.69 million.
The earnings report led to a positive response in the stock price, with one participant noting a "nice" reaction.
Another participant highlighted a technical chart development, specifically the 0.5 fib, which is expected to appear in a group's discussion the next day.

Newcomers· Aug 4

The newcomers are discussing iRhythm Technologies, Inc.'s recent strong Q2 earnings and the 17% stock price increase.
Newcomers are focused on the technical analysis and stock market implications of iRhythm's earnings, as well as the company's raised guidance.
The newcomers are also looking at irhythm stock analysis, specifically after the strong earnings release, as a way to understand the company's performance.

Generated by AI

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how patient monitoring stocks fared in Q2, starting with iRhythm (NASDAQ:IRTC).

8d agoYahoo Finance

iRhythm at Wells Fargo 21st annual healthcare conference: vitalconnect deal expands reach

21d agoInvesting.com

Mobile ECG Devices Market Outlook 2025-2035 Featuring Profiles AliveCor, Apple and iRhythm Technologies - Industry Forecast to Reach $9.03 Billion by 2035 as Remote Cardiac Monitoring Adoption Accelerates

Opportunities center on AI-enabled wearable ECG bands, remote monitoring, point-of-care diagnostics and home use, driven by telemedicine and preventive care, especially in emerging markets. Mobile ECG Devices Market Mobile ECG Devices Market Dublin, Sept. 02, 2026 (GLOBE NEWSWIRE) -- The "Mobile ECG Devices Global Market Opportunities and Strategies to 2035" has been added to ResearchAndMarkets.com's offering. The global mobile ECG devices market is experiencing strong growth as healthcare provi

28d agoYahoo Finance

iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference

SAN FRANCISCO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will...

1mo agobarchart.com

iRhythm Holdings (IRTC) Faces An Audit Committee Shift As Its Undervalued Narrative Holds

iRhythm Holdings (IRTC) informed investors that Board member and Audit Committee chair Brian Yoor resigned for personal reasons on August 12, 2026. Existing director Karen McGinnis will step in to chair the Audit Committee. iRhythm Holdings’ share price has been volatile over 2026, with a 30 day share price return of 12.72% and a 7 day gain of 6.81%. However, the year to date share price return is down 29.75% and the 1 year total shareholder return is down 26.74%, even though the 5 year total...

1mo agoYahoo Finance

iRhythm: The Algorithmic Margin Inflection Changes The Story (NASDAQ:IRTC)

1mo agoSeeking Alpha

Also Discussed

Investors talking about IRTC also mention

#	Name	Attention
1	HeartBeam, Inc.BEAT	0%+0
2	NARI - Inari Medical, Inc.	——
3	Guardant Health Inc.GH	0%-0.11
4	WhiteHorse Finance, Inc. - 7.875% Notes due 2028WHFCL	0%new
5	EXAS - Exact Sciences Corporation	——
6	Envista Holdings Corp.NVST	0%0
7	Azenta, Inc.AZTA	0%0
8	Onto Innovation Inc.ONTO	0%-0.02
9	ASGN Inc.ASGN	0%0
10	Brookfield Business Corporation Class A Subordinate Voting SharesBBUC	0%-0.01

iRhythm Holdings, Inc.

Healthcare
Medical Devices

iRhythm Holdings, Inc. is a digital healthcare company focused on ambulatory cardiac monitoring and arrhythmia detection. The company develops and commercializes wearable, device-based technology that helps clinicians capture and analyze heart rhythm data outside of the hospital setting. Its product portfolio includes remote ECG monitoring systems and connected software tools that support physician review, patient data collection, and clinical workflow management. iRhythm Holdings serves cardiology, electrophysiology, primary care, and other specialty practices that rely on timely rhythm assessment to guide diagnosis. The company’s platform combines biosensors, cloud-based analytics, and proprietary algorithms to turn long-duration heartbeat data into clinically useful reports. Headquartered in San Francisco, iRhythm Holdings operates in the healthcare technology and medical devices market, where it plays a specialized role in noninvasive cardiac diagnostics.

Website

Location

699 8th Street

San Francisco, CA, 94103

United States

Social

What share of all stock conversation is about IRTC?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% 0	0% 0

Jun 15

IRTC is breaking above its 50-day moving average, signaling a strong bullish trend.
The stochastic oscillator and MACD for IRTC are pointing upwards, indicating bullish momentum and potential for further upside.
IRTC is developing a bullish flag pattern and has solid bullish momentum, with potential for a breakout above key resistance levels.

Generated by AI

Sentiment

Of the messages about IRTC that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	100% +50	85.07% -4.87
Bearish	—	0%	0% -50	14.93% +4.87

Bullish· Jan 14

Citigroup and Canaccord Genuity both raised iRhythm Technologies' price target, with Citigroup setting a new target of $165 and Canaccord Genuity setting a new target of $160.
Analysts' consensus on iRhythm Technologies is mildly bullish, with 79% of 16 analysts recommending a "Buy" rating.
The company's updated reimbursement rates have led to increased price targets from several Wall Street analysts, with Citigroup and Canaccord Genuity being two of the firms making such changes.

Bearish· Nov 4

$IRTC's recent price movement may be a fake pump, and the stock could correct significantly after earnings.
The company's FY21 sales guidance cut has led to a decline in iRhythm Technologies shares trading after hours.
iRhythm Technologies' FQ3 earnings report showed a loss of 81c EPS and $85.43M in revenue, which may indicate a downward trend for the stock.

Generated by AI

Topics

Of the messages about IRTC that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	17.16%
Announcements	—	—	—	71.64%
Earnings	—	—	—	5.22%
Controversies	—	—	—	0.75%
Macro	—	—	—	0%
Technical Analysis	—	—	—	5.22%

Earnings· Nov 5

iRhythm Technologies (IRTC) reported Q3 GAAP EPS of -$0.74, missing estimates by $0.37.
Revenue for the quarter came in at $55.96M, beating estimates by $2.2M.
The company guided FY19 revenue in-line with expectations.

Analysts· Feb 24

Morgan Stanley cut iRhythm Technologies' price target to $151.00, maintaining an Overweight rating.
Needham upgraded iRhythm Technologies to Buy from Hold, setting a price target of $135.
Morgan Stanley maintained an Overweight rating for iRhythm Technologies, lowering the price target from $167 to $151.

Announcements· Mar 5

iRhythm Technologies, Inc. (IRTC) priced an upsized offering of $575.0 million of 1.50% convertible senior notes due 2029.
The company has increased shareholder value and expanded funding opportunities with this offering.
Quentin S., an insider, sold $3.0 million worth of iRhythm Technologies shares in the Health Care sector.

Generated by AI

Community

Of the messages about IRTC, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	92.31%	35.11%
Newcomers	—	0%	7.69%	64.89%

Regulars· Aug 1

The company reported a Q2 loss of $0.32 per share, beating the FactSet consensus by $0.17, and saw revenues rise 26.1% year-over-year to $186.69 million.
The earnings report led to a positive response in the stock price, with one participant noting a "nice" reaction.
Another participant highlighted a technical chart development, specifically the 0.5 fib, which is expected to appear in a group's discussion the next day.

Newcomers· Aug 4

The newcomers are discussing iRhythm Technologies, Inc.'s recent strong Q2 earnings and the 17% stock price increase.
Newcomers are focused on the technical analysis and stock market implications of iRhythm's earnings, as well as the company's raised guidance.
The newcomers are also looking at irhythm stock analysis, specifically after the strong earnings release, as a way to understand the company's performance.

Generated by AI

iRhythm Holdings

Social

Jun 15

Bullish· Jan 14

Bearish· Nov 4

Earnings· Nov 5

Analysts· Feb 24

Announcements· Mar 5

Regulars· Aug 1

Newcomers· Aug 4

Firing on All Cylinders: iRhythm (NASDAQ:IRTC) Q2 Earnings Lead the Way

iRhythm at Wells Fargo 21st annual healthcare conference: vitalconnect deal expands reach

Mobile ECG Devices Market Outlook 2025-2035 Featuring Profiles AliveCor, Apple and iRhythm Technologies - Industry Forecast to Reach $9.03 Billion by 2035 as Remote Cardiac Monitoring Adoption Accelerates

iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference

iRhythm Holdings (IRTC) Faces An Audit Committee Shift As Its Undervalued Narrative Holds

iRhythm: The Algorithmic Margin Inflection Changes The Story (NASDAQ:IRTC)

Also Discussed

iRhythm Holdings, Inc.

Company Information

Location

Firing on All Cylinders: iRhythm (NASDAQ:IRTC) Q2 Earnings Lead the Way

iRhythm at Wells Fargo 21st annual healthcare conference: vitalconnect deal expands reach

Mobile ECG Devices Market Outlook 2025-2035 Featuring Profiles AliveCor, Apple and iRhythm Technologies - Industry Forecast to Reach $9.03 Billion by 2035 as Remote Cardiac Monitoring Adoption Accelerates

iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference

iRhythm Holdings (IRTC) Faces An Audit Committee Shift As Its Undervalued Narrative Holds

iRhythm: The Algorithmic Margin Inflection Changes The Story (NASDAQ:IRTC)

Also Discussed

Social

Jun 15

Bullish· Jan 14

Bearish· Nov 4

Earnings· Nov 5

Analysts· Feb 24

Announcements· Mar 5

Regulars· Aug 1

Newcomers· Aug 4